Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01329016 · ClinicalTrials.gov registry record · Phase 1
Glyburide and Metformin for Gestational Diabetes Mellitus (GDM)
A Phase 1 study, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- Completed
- Registry status
- Phase 1
- Development phase
- 177
- Enrollment target
NCT01329016 is a Phase 1 study that has completed, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The registered enrollment target is 177 participants.
The verdict
NCT01329016, a Phase 1 study, has completed, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 177 participants
- Enrollment target
Study Summary
This is a pharmacokinetic and pharmacodynamic study evaluating glyburide, metformin, and combination treatment for gestational diabetes mellitus.
Interventions
- DRUG Metformin
- DRUG Glyburide
- DRUG Glyburide-Metformin combination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 177 participants |
| Start Date | 2011-07 |
| Est. Completion | 2015-02-28 |
| Phase | Phase 1 |
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)305 total trials
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01329016
The ClinicalTrials.gov registry entry for NCT01329016 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 177 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Metformin is the first listed.
NCT01329016 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01329016 about?
NCT01329016 is a clinical study titled "Glyburide and Metformin for Gestational Diabetes Mellitus (GDM)". This is a pharmacokinetic and pharmacodynamic study evaluating glyburide, metformin, and combination treatment for gestational diabetes mellitus.
What is the current status of trial NCT01329016?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 177 participants. The study started on 2011-07. Estimated completion is 2015-02-28.
What interventions are being tested in trial NCT01329016?
The interventions under investigation include: Metformin (DRUG), Glyburide (DRUG), Glyburide-Metformin combination (DRUG).
Who is sponsoring clinical trial NCT01329016?
This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.